These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31951183)

  • 1. Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation.
    Cardano M; Tribioli C; Prosperi E
    Curr Cancer Drug Targets; 2020; 20(4):240-252. PubMed ID: 31951183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis.
    Actis M; Inoue A; Evison B; Perry S; Punchihewa C; Fujii N
    Bioorg Med Chem; 2013 Apr; 21(7):1972-7. PubMed ID: 23395113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small molecule inhibitor of monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits repair of interstrand DNA cross-link, enhances DNA double strand break, and sensitizes cancer cells to cisplatin.
    Inoue A; Kikuchi S; Hishiki A; Shao Y; Heath R; Evison BJ; Actis M; Canman CE; Hashimoto H; Fujii N
    J Biol Chem; 2014 Mar; 289(10):7109-7120. PubMed ID: 24474685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy.
    Søgaard CK; Otterlei M
    Adv Pharmacol; 2024; 100():209-246. PubMed ID: 39034053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effects of a small molecular PCNA inhibitor PCNA-I1S and DNA damaging agents on growth inhibition and DNA damage in prostate and lung cancer cells.
    Lu S; Dong Z
    PLoS One; 2019; 14(10):e0223894. PubMed ID: 31600334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of a novel small molecule targeting PCNA chromatin association in prostate cancer.
    Dillehay KL; Lu S; Dong Z
    Mol Cancer Ther; 2014 Dec; 13(12):2817-26. PubMed ID: 25253786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCNA: a silent housekeeper or a potential therapeutic target?
    Wang SC
    Trends Pharmacol Sci; 2014 Apr; 35(4):178-86. PubMed ID: 24655521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells.
    Müller R; Misund K; Holien T; Bachke S; Gilljam KM; Våtsveen TK; Rø TB; Bellacchio E; Sundan A; Otterlei M
    PLoS One; 2013; 8(7):e70430. PubMed ID: 23936203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of proliferating cell nuclear antigen (PCNA) associated with DNA.
    Scovassi AI; Prosperi E
    Methods Mol Biol; 2006; 314():457-75. PubMed ID: 16673899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA.
    Gu L; Lingeman R; Yakushijin F; Sun E; Cui Q; Chao J; Hu W; Li H; Hickey RJ; Stark JM; Yuan YC; Chen Y; Vonderfecht SL; Synold TW; Shi Y; Reckamp KL; Horne D; Malkas LH
    Clin Cancer Res; 2018 Dec; 24(23):6053-6065. PubMed ID: 29967249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death.
    Shemesh A; Kundu K; Peleg R; Yossef R; Kaplanov I; Ghosh S; Khrapunsky Y; Gershoni-Yahalom O; Rabinski T; Cerwenka A; Atlas R; Porgador A
    Front Immunol; 2018; 9():1114. PubMed ID: 29875773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating the disruption of proliferating cell nuclear antigen interactions in the development of targeted cancer therapeutics.
    Smith SJ; Hickey RJ; Malkas LH
    Cancer Biol Ther; 2016; 17(3):310-9. PubMed ID: 26889573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth.
    Tan Z; Wortman M; Dillehay KL; Seibel WL; Evelyn CR; Smith SJ; Malkas LH; Zheng Y; Lu S; Dong Z
    Mol Pharmacol; 2012 Jun; 81(6):811-9. PubMed ID: 22399488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth.
    Zhao H; Lo YH; Ma L; Waltz SE; Gray JK; Hung MC; Wang SC
    Mol Cancer Ther; 2011 Jan; 10(1):29-36. PubMed ID: 21220489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fellowship of the rings: distinct pools of proliferating cell nuclear antigen trimer at work.
    Prosperi E
    FASEB J; 2006 May; 20(7):833-7. PubMed ID: 16675840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule targeting of transcription-replication conflict for selective chemotherapy.
    Gu L; Li M; Li CM; Haratipour P; Lingeman R; Jossart J; Gutova M; Flores L; Hyde C; Kenjić N; Li H; Chung V; Li H; Lomenick B; Von Hoff DD; Synold TW; Aboody KS; Liu Y; Horne D; Hickey RJ; Perry JJP; Malkas LH
    Cell Chem Biol; 2023 Oct; 30(10):1235-1247.e6. PubMed ID: 37531956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear IGF1R interact with PCNA to preserve DNA replication after DNA-damage in a variety of human cancers.
    Yang C; Zhang Y; Chen Y; Ragaller F; Liu M; Corvigno S; Dahlstrand H; Carlson J; Chen Z; Näsman A; Waraky A; Lin Y; Larsson O; Haglund F
    PLoS One; 2020; 15(7):e0236291. PubMed ID: 32701997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ub-family modifications at the replication fork: Regulating PCNA-interacting components.
    Kirchmaier AL
    FEBS Lett; 2011 Sep; 585(18):2920-8. PubMed ID: 21846465
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
    World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A site-selective, irreversible inhibitor of the DNA replication auxiliary factor proliferating cell nuclear antigen (PCNA).
    Evison BJ; Actis ML; Wu SZ; Shao Y; Heath RJ; Yang L; Fujii N
    Bioorg Med Chem; 2014 Nov; 22(22):6333-43. PubMed ID: 25438756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.